Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Clumeck

Showing results (131-140 of 191) with videos related to

Pageof 20
Sort By:
The Journal of Infectious Diseases|November 1, 1995
Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccineF Mascart-Lemone, M Gérard, M Libin, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Attitudes and opinions toward HIV infection of 1,008 participants to the Vth International Conference on AIDS Montreal, 4-9 June 1989U Tirelli, S Micheluz, S Franceschi, et al.
Antiviral Therapy|March 7, 2002
Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study)E Florence, C Dreezen, P Desmet, et al.
European Journal of Clinical Microbiology|June 1, 1985
Analysis of the interferon system in African patients with acquired immunodeficiency syndromeK Huygen, F Mascart-Lemone, S Cran, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2007
Hepatotoxicity observed in clinical trials of aplaviroc (GW873140)W G Nichols, H M Steel, T Bonny, et al.
AIDS (London, England)|May 1, 1997
A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasisS De Wit, B Dupont, J D Cartledge, et al.
HIV Medicine|April 19, 2003
TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence resultsC Katlama, S Fenske, B Gazzard, et al.
Science (New York, N.Y.)|March 22, 1985
Bovine leukemia virus-related antigens in lymphocyte cultures infected with AIDS-associated virusesL Thiry, S Sprecher-Goldberger, P Jacquemin, et al.
Lancet (London, England)|October 19, 1985
Isolation of AIDS virus from cell-free breast milk of three healthy virus carriersL Thiry, S Sprecher-Goldberger, T Jonckheer, et al.
JAMA|November 8, 1985
Seroepidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual AfricansN Clumeck, M Robert-Guroff, P Van de Perre, et al.
Pageof 20

Showing results (131-140 of 191) with videos related to

Sort By:
Pageof 20
The Journal of Infectious Diseases|November 1, 1995
Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccineF Mascart-Lemone, M Gérard, M Libin, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Attitudes and opinions toward HIV infection of 1,008 participants to the Vth International Conference on AIDS Montreal, 4-9 June 1989U Tirelli, S Micheluz, S Franceschi, et al.
Antiviral Therapy|March 7, 2002
Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study)E Florence, C Dreezen, P Desmet, et al.
European Journal of Clinical Microbiology|June 1, 1985
Analysis of the interferon system in African patients with acquired immunodeficiency syndromeK Huygen, F Mascart-Lemone, S Cran, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2007
Hepatotoxicity observed in clinical trials of aplaviroc (GW873140)W G Nichols, H M Steel, T Bonny, et al.
AIDS (London, England)|May 1, 1997
A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasisS De Wit, B Dupont, J D Cartledge, et al.
HIV Medicine|April 19, 2003
TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence resultsC Katlama, S Fenske, B Gazzard, et al.
Science (New York, N.Y.)|March 22, 1985
Bovine leukemia virus-related antigens in lymphocyte cultures infected with AIDS-associated virusesL Thiry, S Sprecher-Goldberger, P Jacquemin, et al.
Lancet (London, England)|October 19, 1985
Isolation of AIDS virus from cell-free breast milk of three healthy virus carriersL Thiry, S Sprecher-Goldberger, T Jonckheer, et al.
JAMA|November 8, 1985
Seroepidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual AfricansN Clumeck, M Robert-Guroff, P Van de Perre, et al.
Pageof 20